Colossal Biosciences (Series B)

Funding Details
Awarder
RSS - techcrunch.com
Date Award
January 22, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Valuation
$10,200,000

Company Info
Company Description
Colossal Biosciences is focused on de-extinction efforts, specifically aiming to bring back woolly mammoths through advanced genetic engineering techniques. The company has raised significant funding to support its ambitious project, which involves using CRISPR technology to edit the genes of Asian elephants to create a hybrid species that resembles the woolly mammoth.
Market
Genetics
Location
US

Links
Back to Home Back to Biotechnology Deals View Funding Announcement